InnoCare and ArriVent Announce Clinical Development

Companies will collaborate on investigating a novel SHP2 inhibitor in combination with furmonertinib, a highly brain-penetrant, broadly active...

Related Keywords

China ,United States ,Shanghai ,Hong Kong ,Beijing ,Nanjing ,Jiangsu ,Guangzhou ,Guangdong ,Jasmine Cui ,Chunhua Lu ,Arrivent Biopharma ,Innocare Pharma ,Amy Bonanno ,Bing Yao ,Allist Pharmaceuticals ,Care Pharma ,Src Homology ,Chief Executive Officer ,